The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients

Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and di...

Full description

Saved in:
Bibliographic Details
Published inMetabolism, clinical and experimental Vol. 61; no. 2; pp. 242 - 249
Main Authors Lee, Mei-Yueh, Lin, Kun-Der, Hsiao, Pi-Jung, Shin, Shyi-Jang
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.02.2012
Elsevier
Subjects
Online AccessGet full text
ISSN0026-0495
1532-8600
1532-8600
DOI10.1016/j.metabol.2011.06.020

Cover

Abstract Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ 2 test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.
AbstractList Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985,815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ(2) test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104,343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.
Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ² test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.
Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ 2 test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.
Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985,815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ(2) test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104,343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985,815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ(2) test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104,343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.
Abstract Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ2 test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.
Author Shin, Shyi-Jang
Lin, Kun-Der
Hsiao, Pi-Jung
Lee, Mei-Yueh
Author_xml – sequence: 1
  givenname: Mei-Yueh
  surname: Lee
  fullname: Lee, Mei-Yueh
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
– sequence: 2
  givenname: Kun-Der
  surname: Lin
  fullname: Lin, Kun-Der
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
– sequence: 3
  givenname: Pi-Jung
  surname: Hsiao
  fullname: Hsiao, Pi-Jung
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
– sequence: 4
  givenname: Shyi-Jang
  surname: Shin
  fullname: Shin, Shyi-Jang
  email: sjshin@kmu.edu.tw
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25563779$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21820134$$D View this record in MEDLINE/PubMed
BookMark eNqNkktv1DAUhS1URKcDPwHkDaKLmcFO4jyEAKGKl1SJBcPacpybzh0SO9hOq_k3_ak4M1MhVYKyyUM65_P1ueeMnBhrgJDnnK044_nr7aqHoGrbrRLG-YrlK5awR2TGRZosy5yxEzJjLMmXLKvEKTnzfssYK4oyf0JOE15GV5rNyO16A1R5bzWqgNZQ29IGVQ0BPO2h6zCMnt5g2NAOr8EtqLadNQvajeZqQZVp6OCsDyoA1cpocBQ9RdPAAPFhwgTc7AZwAYzHybn_63DABnpUB8aVHUN00bXCG2XAAx3iONHun5LHreo8PDu-5-THp4_riy_Ly2-fv158uFxqkeZhWYFoyjptygISVpdtq0ReN1mZZEJXbQwlBa5SzpRQPFE8rVnW8rYushhJ3VZVOievDtx4nV8j-CB79DoGEMexo5cVL0qRZxE0J-f_VPIiTYXIOZugL47Sse6hkYPDXrmdvMs_Cl4eBcpr1bUuRoj-jy5y0qKYQG8OOh3D9g5aqTHsFxacwk5yJqdWyK08tkJOrZAsl7EV0S3uue8OeMj3_uCDGPw1gpNex6VoaNCBDrKx-CDh3T2C7tBgvOpP2IHf2tGZuFXJpU8kk9-nxk6F5Tx-sX2Cb_8O-I8BfgNMtP-R
CitedBy_id crossref_primary_10_1016_j_esmoop_2022_100518
crossref_primary_10_1016_j_metabol_2012_03_011
crossref_primary_10_1007_s00125_017_4229_z
crossref_primary_10_1021_acs_analchem_4c04671
crossref_primary_10_1634_theoncologist_2013_0177
crossref_primary_10_1016_j_ejca_2014_08_007
crossref_primary_10_1021_acs_jnatprod_1c00014
crossref_primary_10_3892_ol_2017_7370
crossref_primary_10_1016_j_prnil_2018_11_001
crossref_primary_10_3390_cells8040326
crossref_primary_10_1371_journal_pone_0101553
crossref_primary_10_1016_j_lungcan_2014_09_012
crossref_primary_10_1371_journal_pone_0229176
crossref_primary_10_1021_es305295d
crossref_primary_10_1039_D0RA06642G
crossref_primary_10_1371_journal_pone_0056662
crossref_primary_10_22465_kjuo_2019_17_3_119
crossref_primary_10_3389_fonc_2019_01404
crossref_primary_10_1111_ajco_12084
crossref_primary_10_2337_dcS13_2031
crossref_primary_10_1177_1179554919835798
crossref_primary_10_1620_tjem_228_267
crossref_primary_10_1093_annonc_mdt017
crossref_primary_10_1007_s00592_013_0471_0
crossref_primary_10_1016_j_jseaes_2013_04_048
crossref_primary_10_1186_1471_2407_13_310
crossref_primary_10_1016_j_jtho_2017_01_021
crossref_primary_10_3892_ol_2017_7412
crossref_primary_10_1016_j_tem_2016_02_006
crossref_primary_10_1111_ecc_12084
crossref_primary_10_1007_s40200_019_00391_5
crossref_primary_10_1002_ijc_28989
crossref_primary_10_1210_jc_2018_02289
crossref_primary_10_6000_1929_2279_2014_03_04_3
crossref_primary_10_5534_wjmh_240022
crossref_primary_10_1016_j_ejca_2014_06_019
crossref_primary_10_1016_j_cmpb_2016_01_009
crossref_primary_10_1155_2012_801610
crossref_primary_10_3748_wjg_v20_i28_9541
crossref_primary_10_1002_ijc_31365
crossref_primary_10_3390_gidisord1020023
crossref_primary_10_1038_pcan_2012_40
crossref_primary_10_1111_cas_12235
crossref_primary_10_1186_s12885_015_1847_z
crossref_primary_10_3390_cancers14030555
crossref_primary_10_1186_1471_2407_12_413
crossref_primary_10_7314_APJCP_2012_13_8_4097
crossref_primary_10_1007_s10654_013_9865_0
crossref_primary_10_1007_s11606_024_09076_z
crossref_primary_10_1530_ERC_16_0222
crossref_primary_10_1016_j_ejca_2012_03_007
crossref_primary_10_1007_s11428_013_1068_5
crossref_primary_10_7759_cureus_40058
crossref_primary_10_1111_jdi_12112
crossref_primary_10_1371_journal_pone_0125421
crossref_primary_10_1007_s00592_012_0439_5
crossref_primary_10_6118_jmm_19014
crossref_primary_10_1093_carcin_bgu135
crossref_primary_10_1080_13543784_2017_1333104
crossref_primary_10_3389_fmed_2023_1118863
crossref_primary_10_3390_ijerph110908645
crossref_primary_10_7314_APJCP_2014_15_3_1447
crossref_primary_10_3390_jcm14020411
crossref_primary_10_1007_s00432_013_1407_3
crossref_primary_10_1016_j_critrevonc_2013_06_011
crossref_primary_10_3390_cancers13081982
crossref_primary_10_1097_CEJ_0000000000000361
crossref_primary_10_1002_cam4_1685
crossref_primary_10_1016_j_bmcl_2017_08_035
crossref_primary_10_1016_j_metabol_2014_04_014
crossref_primary_10_1155_2012_413782
crossref_primary_10_1155_2013_583786
crossref_primary_10_1016_j_genrep_2016_06_003
crossref_primary_10_1097_MD_0000000000006627
Cites_doi 10.1093/jnci/dji375
10.2337/dc10-0666
10.1373/clinchem.2008.115352
10.1093/oxfordjournals.aje.a009534
10.1002/ijc.23192
10.1073/pnas.78.11.6858
10.1016/S0022-2275(20)32407-X
10.1677/ERC-09-0087
10.1016/j.cgh.2005.12.007
10.1200/JCO.2006.07.2777
10.1002/ijc.22717
10.1002/anr.1780321114
10.1038/nrc2734
10.2174/187152608784746501
10.1016/S1726-4901(09)70195-9
10.1093/annonc/mdm338
10.1016/S0003-9861(03)00283-2
10.1016/j.ejca.2006.01.012
10.2174/138920106779116928
10.1038/sj.ijir.3901031
10.1073/pnas.87.19.7638
10.1152/ajpendo.2001.280.5.E745
10.1158/1055-9965.EPI-06-0410
10.1111/j.1572-0241.2006.00725.x
10.1016/S0140-6736(06)68770-9
10.1016/0304-3835(88)90023-7
10.1136/gut.2004.052167
10.1097/CEJ.0b013e328313631a
10.7326/0003-4819-117-10-807
ContentType Journal Article
Copyright 2012 Elsevier Inc.
Elsevier Inc.
2015 INIST-CNRS
Copyright © 2012 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2012 Elsevier Inc.
– notice: Elsevier Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7S9
L.6
7X8
DOI 10.1016/j.metabol.2011.06.020
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE
AGRICOLA

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1532-8600
EndPage 249
ExternalDocumentID 21820134
25563779
10_1016_j_metabol_2011_06_020
S0026049511002009
1_s2_0_S0026049511002009
Genre Journal Article
GeographicLocations Asia
Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYJJ
AAYWO
ABBQC
ABDPE
ABFNM
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACIEU
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AEVXI
AFFNX
AFJKZ
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LZ1
M29
M41
MO0
MVM
N9A
O-L
O9-
OAUVE
OB0
OHT
ON-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UAP
UHS
WUQ
X7M
Z5R
ZGI
~G-
~KM
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
PKN
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
DOVZS
EFLBG
G8K
LCYCR
ZA5
AAYXX
ACLOT
CITATION
~HD
AGRNS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7S9
L.6
7X8
ID FETCH-LOGICAL-c536t-9e5d8b3d87e20b8ffa56bd48245c9f1533e1a310a5a12a13b04f1fb74077bf993
IEDL.DBID .~1
ISSN 0026-0495
1532-8600
IngestDate Sun Sep 28 02:11:31 EDT 2025
Sat Sep 27 18:56:31 EDT 2025
Mon Jul 21 06:05:10 EDT 2025
Mon Jul 21 09:10:50 EDT 2025
Wed Oct 01 05:14:27 EDT 2025
Thu Apr 24 23:05:21 EDT 2025
Fri Feb 23 02:21:21 EST 2024
Sun Feb 23 10:20:06 EST 2025
Tue Aug 26 19:44:51 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Endocrinopathy
Prostate disease
Lung cancer
Gout
Diseases of the osteoarticular system
Cardiovascular disease
Hepatic disease
Lipids
Liver cancer
Hyperuricemia
Association
Colon cancer
Intestinal disease
Bronchus disease
Hyperlipemia
Dyslipemia
Male genital diseases
Human
Hypertension
Lung disease
Urinary system disease
Respiratory disease
Diabetes mellitus
Metabolic diseases
Malignant tumor
Uric acid
Microcristalline arthropathy
Colonic disease
Digestive diseases
Purine
Prostate cancer
Microcrystal
Endocrinology
Cancer
Language English
License CC BY 4.0
Copyright © 2012 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-9e5d8b3d87e20b8ffa56bd48245c9f1533e1a310a5a12a13b04f1fb74077bf993
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21820134
PQID 1733556109
PQPubID 24069
PageCount 8
ParticipantIDs proquest_miscellaneous_917856453
proquest_miscellaneous_1733556109
pubmed_primary_21820134
pascalfrancis_primary_25563779
crossref_citationtrail_10_1016_j_metabol_2011_06_020
crossref_primary_10_1016_j_metabol_2011_06_020
elsevier_sciencedirect_doi_10_1016_j_metabol_2011_06_020
elsevier_clinicalkeyesjournals_1_s2_0_S0026049511002009
elsevier_clinicalkey_doi_10_1016_j_metabol_2011_06_020
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-02-01
PublicationDateYYYYMMDD 2012-02-01
PublicationDate_xml – month: 02
  year: 2012
  text: 2012-02-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Metabolism, clinical and experimental
PublicationTitleAlternate Metabolism
PublicationYear 2012
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Chen (bb0025) 2009
Kaaks (bb0105) 1996; 7
Kern, Ranganathan, Li (bb0130) 2001; 280
Larsson, Orsini, Wolk (bb0060) 2005; 97
Giovannucci, Harlan, Archer (bb0020) 2009
Shuman (bb0110) 2008
Strasak, Rapp, Hilbe (bb0160) 2007; 18
Guerne, Terkeltaub, Zuraw (bb0175) 1989; 32
Betancourt-Albrecht, Cunningham (bb0095) 2003; 15
Larsson, Mantzoros, Wolk (bb0100) 2007; 121
Barrett-Connor (bb0090) 1992; 117
Peden, Hohman, Brown (bb0170) 1990; 87
Giovannucci, Harlan, Archer (bb0010) 2010; 33
Kasper, Giovannucci (bb0085) 2006; 15
Szlosarek, Charles, Balkwill (bb0135) 2006; 42
Hudgins, Hellerstein, Seidman (bb0140) 2000; 41
Chiang (bb0015)
Stadler, Yeung, Furrer (bb0070) 1988; 38
Govindarajan, Ratnasinghe, Simmons (bb0080) 2007; 25
Boffetta, Nordenvall, Nyrén (bb0155) 2009; 18
(bb0035) 2008
Chen, Li, Chen (bb0055) 2006; 69
Heuson, Legros (bb0040) 1972; 32
Menendez, Vazquez-Martin, Ortega (bb0150) 2009; 55
Ames, Cathcart, Schweirs (bb0165) 1981; 78
Federico, Morgillo, Tuccillo (bb0115) 2007; 121
Cebioglu, Schild, Golubnitschaja (bb0125) 2008; 8
Lopez, Mathers, Ezzati (bb0030) 2006; 367
El-Serag, Hampel, Javadi (bb0045) 2006; 4
Limburg, Vierkant, Fredericksen (bb0065) 2006; 101
Lupu, Menendez (bb0145) 2006; 7
Davila, Morgan, Shaib (bb0050) 2005; 54
Yu, Pardoll, Jove (bb0180) 2009; 9
Vigneri, Frasca, Sciacca (bb0005) 2009; 16
Ohshima, Tatemichi, Sawa (bb0120) 2003; 417
Will, Galuska, Vinicor (bb0075) 1998; 147
Kaaks (10.1016/j.metabol.2011.06.020_bb0105) 1996; 7
Kern (10.1016/j.metabol.2011.06.020_bb0130) 2001; 280
Ames (10.1016/j.metabol.2011.06.020_bb0165) 1981; 78
Federico (10.1016/j.metabol.2011.06.020_bb0115) 2007; 121
Barrett-Connor (10.1016/j.metabol.2011.06.020_bb0090) 1992; 117
Shuman (10.1016/j.metabol.2011.06.020_bb0110) 2008
Boffetta (10.1016/j.metabol.2011.06.020_bb0155) 2009; 18
Govindarajan (10.1016/j.metabol.2011.06.020_bb0080) 2007; 25
Kasper (10.1016/j.metabol.2011.06.020_bb0085) 2006; 15
Davila (10.1016/j.metabol.2011.06.020_bb0050) 2005; 54
(10.1016/j.metabol.2011.06.020_bb0035) 2008
Vigneri (10.1016/j.metabol.2011.06.020_bb0005) 2009; 16
Chen (10.1016/j.metabol.2011.06.020_bb0025) 2009
Betancourt-Albrecht (10.1016/j.metabol.2011.06.020_bb0095) 2003; 15
Strasak (10.1016/j.metabol.2011.06.020_bb0160) 2007; 18
Chen (10.1016/j.metabol.2011.06.020_bb0055) 2006; 69
Lupu (10.1016/j.metabol.2011.06.020_bb0145) 2006; 7
Limburg (10.1016/j.metabol.2011.06.020_bb0065) 2006; 101
Peden (10.1016/j.metabol.2011.06.020_bb0170) 1990; 87
Giovannucci (10.1016/j.metabol.2011.06.020_bb0010) 2010; 33
Ohshima (10.1016/j.metabol.2011.06.020_bb0120) 2003; 417
Cebioglu (10.1016/j.metabol.2011.06.020_bb0125) 2008; 8
Yu (10.1016/j.metabol.2011.06.020_bb0180) 2009; 9
Lopez (10.1016/j.metabol.2011.06.020_bb0030) 2006; 367
Larsson (10.1016/j.metabol.2011.06.020_bb0060) 2005; 97
El-Serag (10.1016/j.metabol.2011.06.020_bb0045) 2006; 4
Will (10.1016/j.metabol.2011.06.020_bb0075) 1998; 147
Szlosarek (10.1016/j.metabol.2011.06.020_bb0135) 2006; 42
Hudgins (10.1016/j.metabol.2011.06.020_bb0140) 2000; 41
Larsson (10.1016/j.metabol.2011.06.020_bb0100) 2007; 121
Giovannucci (10.1016/j.metabol.2011.06.020_bb0020) 2009
Heuson (10.1016/j.metabol.2011.06.020_bb0040) 1972; 32
Chiang (10.1016/j.metabol.2011.06.020_bb0015)
Menendez (10.1016/j.metabol.2011.06.020_bb0150) 2009; 55
Guerne (10.1016/j.metabol.2011.06.020_bb0175) 1989; 32
Stadler (10.1016/j.metabol.2011.06.020_bb0070) 1988; 38
References_xml – volume: 69
  start-page: 146
  year: 2006
  end-page: 152
  ident: bb0055
  article-title: Sero-prevalence of hepatitis B and C in type 2 diabetic patients
  publication-title: J Chinese Med Assoc
– volume: 121
  start-page: 2381
  year: 2007
  end-page: 2386
  ident: bb0115
  article-title: Chronic inflammation and oxidative stress in human carcinogenesis
  publication-title: Int J Cancer
– volume: 4
  start-page: 369
  year: 2006
  end-page: 380
  ident: bb0045
  article-title: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence
  publication-title: Clin Gastroenterol Hepatol
– year: 2008
  ident: bb0110
  publication-title: National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007
– volume: 18
  start-page: 1893
  year: 2007
  end-page: 1897
  ident: bb0160
  article-title: The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women
  publication-title: Ann Oncol
– volume: 42
  start-page: 745
  year: 2006
  end-page: 750
  ident: bb0135
  article-title: Tumour necrosis factor–alpha as a tumour promoter
  publication-title: Euro J Cancer
– volume: 15
  start-page: S14
  year: 2003
  end-page: S20
  ident: bb0095
  article-title: Hypo-gonadism and diabetes
  publication-title: Int J Impot Res
– ident: bb0015
  article-title: Bureau of National Health Insurance
– volume: 117
  start-page: 807
  year: 1992
  end-page: 811
  ident: bb0090
  article-title: Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus
  publication-title: Ann Intern Med
– volume: 54
  start-page: 533
  year: 2005
  end-page: 539
  ident: bb0050
  article-title: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
  publication-title: Gut
– volume: 78
  start-page: 6858
  year: 1981
  end-page: 6862
  ident: bb0165
  article-title: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis
  publication-title: Proc Natl Acad Sci U S A
– year: 2009
  ident: bb0025
  publication-title: Department of Health
– volume: 25
  start-page: 1476
  year: 2007
  end-page: 1481
  ident: bb0080
  article-title: Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
  publication-title: J Clin Oncol
– volume: 87
  start-page: 7638
  year: 1990
  end-page: 7642
  ident: bb0170
  article-title: Uric acid is a major antioxidant in human nasal airway secretions
  publication-title: Proc Natl Acad Sci U S A
– volume: 16
  start-page: 1103
  year: 2009
  end-page: 1123
  ident: bb0005
  article-title: Diabetes and cancer
  publication-title: Endocr Relat Cancer
– year: 2009
  ident: bb0020
  publication-title: IDF diabetes Atlas [article online]
– volume: 367
  start-page: 1747
  year: 2006
  end-page: 1757
  ident: bb0030
  article-title: Global and regional burden of disease and risk factors, 200: systematic analysis of population health data
  publication-title: Lancet
– volume: 32
  start-page: 226
  year: 1972
  end-page: 232
  ident: bb0040
  article-title: Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction
  publication-title: Cancer Res
– volume: 7
  start-page: 483
  year: 2006
  end-page: 493
  ident: bb0145
  article-title: Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
  publication-title: Curr Pharma Biotech
– volume: 8
  start-page: 76
  year: 2008
  end-page: 87
  ident: bb0125
  article-title: Diabetes mellitus as a risk factor for cancer: stress or viral etiology?
  publication-title: Infect Disord Drug Targets
– volume: 280
  start-page: E745
  year: 2001
  end-page: E751
  ident: bb0130
  article-title: Adipose tissue tumor necrosis factor and interleukin- 6 expression in human obesity and insulin resistance
  publication-title: Am J Physiol Endocrinol Metabol
– volume: 121
  start-page: 856
  year: 2007
  end-page: 862
  ident: bb0100
  article-title: Diabetes mellitus and risk of breast cancer: a meta-analysis
  publication-title: Int J Cancer
– volume: 9
  start-page: 798
  year: 2009
  end-page: 809
  ident: bb0180
  article-title: STATs in cancer inflammation and immunity: a leading role for STAT3
  publication-title: Nat Rev Cancer
– volume: 33
  start-page: 1674
  year: 2010
  end-page: 1685
  ident: bb0010
  article-title: Diabetes and cancer: a consensus report
  publication-title: Diabetes Care
– volume: 41
  start-page: 595
  year: 2000
  end-page: 604
  ident: bb0140
  article-title: Relationship between carbohydrate-induced hyper-triglyceridemia and fatty acid synthesis in lean and obese subjects
  publication-title: J Lipid Res
– volume: 15
  start-page: 2056
  year: 2006
  end-page: 2062
  ident: bb0085
  article-title: A meta-analysis of diabetes mellitus and the risk of prostate cancer
  publication-title: Cancer Epidemiol Biomarkers Prevent
– volume: 32
  start-page: 1443
  year: 1989
  end-page: 1452
  ident: bb0175
  article-title: Inflammatory micro-crystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes
  publication-title: Arthritis Rheum
– volume: 97
  start-page: 1679
  year: 2005
  end-page: 1687
  ident: bb0060
  article-title: Diabetes mellitus and risk of colorectal cancer: a meta-analysis
  publication-title: J Natl Cancer Inst
– year: 2008
  ident: bb0035
  publication-title: World cancer report
– volume: 55
  start-page: 425
  year: 2009
  end-page: 438
  ident: bb0150
  article-title: Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer
  publication-title: Clin Chemistry
– volume: 101
  start-page: 1872
  year: 2006
  end-page: 1879
  ident: bb0065
  article-title: Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population based, retrospective cohort study
  publication-title: Am J Gastroenterol
– volume: 18
  start-page: 127
  year: 2009
  end-page: 132
  ident: bb0155
  article-title: A prospective study of gout and cancer
  publication-title: Eur J Cancer Prev
– volume: 147
  start-page: 816
  year: 1998
  end-page: 825
  ident: bb0075
  article-title: Colorectal cancer: another complication of diabetes mellitus?
  publication-title: Am J Epidemiol
– volume: 38
  start-page: 315
  year: 1988
  end-page: 320
  ident: bb0070
  article-title: Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer
  publication-title: Cancer Letters
– volume: 7
  start-page: 605
  year: 1996
  end-page: 625
  ident: bb0105
  article-title: Nutrition, hormones, and breast cancer: is insulin the missing link?
  publication-title: Cancer Causes Control
– volume: 417
  start-page: 3
  year: 2003
  end-page: 11
  ident: bb0120
  article-title: Chemical basis of inflammation -induced carcinogenesis
  publication-title: Arch Biochem Biophys
– year: 2009
  ident: 10.1016/j.metabol.2011.06.020_bb0025
– volume: 97
  start-page: 1679
  year: 2005
  ident: 10.1016/j.metabol.2011.06.020_bb0060
  article-title: Diabetes mellitus and risk of colorectal cancer: a meta-analysis
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dji375
– volume: 33
  start-page: 1674
  year: 2010
  ident: 10.1016/j.metabol.2011.06.020_bb0010
  article-title: Diabetes and cancer: a consensus report
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0666
– volume: 55
  start-page: 425
  year: 2009
  ident: 10.1016/j.metabol.2011.06.020_bb0150
  article-title: Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer
  publication-title: Clin Chemistry
  doi: 10.1373/clinchem.2008.115352
– volume: 147
  start-page: 816
  year: 1998
  ident: 10.1016/j.metabol.2011.06.020_bb0075
  article-title: Colorectal cancer: another complication of diabetes mellitus?
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a009534
– year: 2009
  ident: 10.1016/j.metabol.2011.06.020_bb0020
– volume: 121
  start-page: 2381
  year: 2007
  ident: 10.1016/j.metabol.2011.06.020_bb0115
  article-title: Chronic inflammation and oxidative stress in human carcinogenesis
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23192
– volume: 78
  start-page: 6858
  year: 1981
  ident: 10.1016/j.metabol.2011.06.020_bb0165
  article-title: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.78.11.6858
– volume: 41
  start-page: 595
  year: 2000
  ident: 10.1016/j.metabol.2011.06.020_bb0140
  article-title: Relationship between carbohydrate-induced hyper-triglyceridemia and fatty acid synthesis in lean and obese subjects
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)32407-X
– volume: 16
  start-page: 1103
  year: 2009
  ident: 10.1016/j.metabol.2011.06.020_bb0005
  article-title: Diabetes and cancer
  publication-title: Endocr Relat Cancer
  doi: 10.1677/ERC-09-0087
– volume: 4
  start-page: 369
  year: 2006
  ident: 10.1016/j.metabol.2011.06.020_bb0045
  article-title: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2005.12.007
– volume: 25
  start-page: 1476
  year: 2007
  ident: 10.1016/j.metabol.2011.06.020_bb0080
  article-title: Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.07.2777
– volume: 121
  start-page: 856
  year: 2007
  ident: 10.1016/j.metabol.2011.06.020_bb0100
  article-title: Diabetes mellitus and risk of breast cancer: a meta-analysis
  publication-title: Int J Cancer
  doi: 10.1002/ijc.22717
– volume: 32
  start-page: 1443
  year: 1989
  ident: 10.1016/j.metabol.2011.06.020_bb0175
  article-title: Inflammatory micro-crystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes
  publication-title: Arthritis Rheum
  doi: 10.1002/anr.1780321114
– volume: 9
  start-page: 798
  year: 2009
  ident: 10.1016/j.metabol.2011.06.020_bb0180
  article-title: STATs in cancer inflammation and immunity: a leading role for STAT3
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2734
– volume: 8
  start-page: 76
  year: 2008
  ident: 10.1016/j.metabol.2011.06.020_bb0125
  article-title: Diabetes mellitus as a risk factor for cancer: stress or viral etiology?
  publication-title: Infect Disord Drug Targets
  doi: 10.2174/187152608784746501
– year: 2008
  ident: 10.1016/j.metabol.2011.06.020_bb0110
– volume: 69
  start-page: 146
  year: 2006
  ident: 10.1016/j.metabol.2011.06.020_bb0055
  article-title: Sero-prevalence of hepatitis B and C in type 2 diabetic patients
  publication-title: J Chinese Med Assoc
  doi: 10.1016/S1726-4901(09)70195-9
– volume: 18
  start-page: 1893
  year: 2007
  ident: 10.1016/j.metabol.2011.06.020_bb0160
  article-title: The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdm338
– volume: 417
  start-page: 3
  year: 2003
  ident: 10.1016/j.metabol.2011.06.020_bb0120
  article-title: Chemical basis of inflammation -induced carcinogenesis
  publication-title: Arch Biochem Biophys
  doi: 10.1016/S0003-9861(03)00283-2
– volume: 42
  start-page: 745
  year: 2006
  ident: 10.1016/j.metabol.2011.06.020_bb0135
  article-title: Tumour necrosis factor–alpha as a tumour promoter
  publication-title: Euro J Cancer
  doi: 10.1016/j.ejca.2006.01.012
– volume: 7
  start-page: 483
  year: 2006
  ident: 10.1016/j.metabol.2011.06.020_bb0145
  article-title: Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
  publication-title: Curr Pharma Biotech
  doi: 10.2174/138920106779116928
– volume: 15
  start-page: S14
  year: 2003
  ident: 10.1016/j.metabol.2011.06.020_bb0095
  article-title: Hypo-gonadism and diabetes
  publication-title: Int J Impot Res
  doi: 10.1038/sj.ijir.3901031
– year: 2008
  ident: 10.1016/j.metabol.2011.06.020_bb0035
– volume: 87
  start-page: 7638
  year: 1990
  ident: 10.1016/j.metabol.2011.06.020_bb0170
  article-title: Uric acid is a major antioxidant in human nasal airway secretions
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.87.19.7638
– volume: 280
  start-page: E745
  year: 2001
  ident: 10.1016/j.metabol.2011.06.020_bb0130
  article-title: Adipose tissue tumor necrosis factor and interleukin- 6 expression in human obesity and insulin resistance
  publication-title: Am J Physiol Endocrinol Metabol
  doi: 10.1152/ajpendo.2001.280.5.E745
– volume: 15
  start-page: 2056
  year: 2006
  ident: 10.1016/j.metabol.2011.06.020_bb0085
  article-title: A meta-analysis of diabetes mellitus and the risk of prostate cancer
  publication-title: Cancer Epidemiol Biomarkers Prevent
  doi: 10.1158/1055-9965.EPI-06-0410
– volume: 32
  start-page: 226
  year: 1972
  ident: 10.1016/j.metabol.2011.06.020_bb0040
  article-title: Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction
  publication-title: Cancer Res
– volume: 101
  start-page: 1872
  year: 2006
  ident: 10.1016/j.metabol.2011.06.020_bb0065
  article-title: Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population based, retrospective cohort study
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2006.00725.x
– volume: 367
  start-page: 1747
  year: 2006
  ident: 10.1016/j.metabol.2011.06.020_bb0030
  article-title: Global and regional burden of disease and risk factors, 200: systematic analysis of population health data
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)68770-9
– volume: 7
  start-page: 605
  year: 1996
  ident: 10.1016/j.metabol.2011.06.020_bb0105
  article-title: Nutrition, hormones, and breast cancer: is insulin the missing link?
  publication-title: Cancer Causes Control
– volume: 38
  start-page: 315
  year: 1988
  ident: 10.1016/j.metabol.2011.06.020_bb0070
  article-title: Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer
  publication-title: Cancer Letters
  doi: 10.1016/0304-3835(88)90023-7
– ident: 10.1016/j.metabol.2011.06.020_bb0015
– volume: 54
  start-page: 533
  year: 2005
  ident: 10.1016/j.metabol.2011.06.020_bb0050
  article-title: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
  publication-title: Gut
  doi: 10.1136/gut.2004.052167
– volume: 18
  start-page: 127
  year: 2009
  ident: 10.1016/j.metabol.2011.06.020_bb0155
  article-title: A prospective study of gout and cancer
  publication-title: Eur J Cancer Prev
  doi: 10.1097/CEJ.0b013e328313631a
– volume: 117
  start-page: 807
  year: 1992
  ident: 10.1016/j.metabol.2011.06.020_bb0090
  article-title: Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-117-10-807
SSID ssj0007786
Score 2.325903
Snippet Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be...
Abstract Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 242
SubjectTerms Adult
Aged
Aged, 80 and over
Asian Continental Ancestry Group - statistics & numerical data
Biological and medical sciences
breast neoplasms
colon
Colonic Neoplasms - complications
Colonic Neoplasms - epidemiology
Colonic Neoplasms - ethnology
confidence interval
Diabetes Complications - epidemiology
Diabetes Complications - ethnology
diabetes mellitus
Diabetes Mellitus - epidemiology
Diabetes Mellitus - ethnology
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinology & Metabolism
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Gastroenterology. Liver. Pancreas. Abdomen
gout
Gout - epidemiology
Gout - ethnology
health insurance
Humans
hyperlipidemia
Hyperlipidemias - epidemiology
Hyperlipidemias - ethnology
hypertension
Hypertension - epidemiology
Hypertension - ethnology
liver
Liver Neoplasms - complications
Liver Neoplasms - epidemiology
Liver Neoplasms - ethnology
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Lung Neoplasms - complications
Lung Neoplasms - epidemiology
Lung Neoplasms - ethnology
lungs
Male
Medical sciences
Middle Aged
patients
Prevalence
prospective studies
prostatic neoplasms
Prostatic Neoplasms - complications
Prostatic Neoplasms - epidemiology
Prostatic Neoplasms - ethnology
regression analysis
risk
sociodemographic characteristics
Taiwan - epidemiology
Tumors
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Title The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0026049511002009
https://www.clinicalkey.es/playcontent/1-s2.0-S0026049511002009
https://dx.doi.org/10.1016/j.metabol.2011.06.020
https://www.ncbi.nlm.nih.gov/pubmed/21820134
https://www.proquest.com/docview/1733556109
https://www.proquest.com/docview/917856453
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1532-8600
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007786
  issn: 0026-0495
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1532-8600
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007786
  issn: 0026-0495
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1532-8600
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007786
  issn: 0026-0495
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1532-8600
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007786
  issn: 0026-0495
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqIhASQlCghI-VkThudhMnTpxjVVEtoPbUSr1ZdmJDqjS72mSFuPBb-KnMxM6uKloVcUyUiR3PZPwmmXlDyEerc82trUIucgsBSmTDomAq1LEqM1OwqGBYnHx6li0u0i-X_HKPHI-1MJhW6X2_8-mDt_Zn5n4156u6xhpfwOKA75H0zBfxIfsX2PTs1y7NA_nRXJoHRM5w9a6KZ341uzY9LHXjmTyzWYRtv2_fn56sVAerZl27i7vx6LAvnTwjTz2gpEduzs_JnmkPyEPXYvLnAXl06n-evyC_wSSo2qmDLi0dP73SayTm7DcdxQ-ztMFsjSlFRut2ShtwCFOq2oqusEYE0Ckt0VjWtO5ove2j2-MNv0Ncux6y4lFyOGpq14VWuXt8W256kKLnqv6hsP8l9dyu3UtycfLp_HgR-gYNYcmTrA8Lwyuhk0rkhkVaWKt4pqtUsJSXhUUkaWIF-FFxFTMVJzpKbQzWAUFkri0go1dkv1225jWhwoiKpYopALBppQG1lSW3TGSWF2WaqYCko1pk6dnLsYlGI8c0tSvptSlRmxLT9VgUkNlWbOXoO-4TyEady7E2FbyphA3mPsH8NkHTeZ_QyVh2TEbyL7sNiNhK3jD9fxl0csMst8-IxHJIJRmQD6OdSvAb-DMINLvcwGzyJMHWqDg-veMaCOUFsg0lATl0Nr4bAIn_4yR98_-Tf0sewxFzKfDvyH6_3pj3gPB6PRle4Ql5cPT56-LsDw0KUmE
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBclZR8wxtZ9eR-dBnuME1u2bPmxlJV0bfKUQt-EZFudi5uE2GHsv9mfurtIdihr6dhjEp8l6y6n38l3vyPkq9Gp5sYUPhepgQAlMH6WMeXrUOVJmbEgY1icPJ0lk4v4-yW_3CPHXS0MplU63299-tZbu2_GbjXHq6rCGl_A4oDvkfTMFvHtxxx88oDsH52eTWa9Q0aKNJvpAcEzCOwKecbXo5uyhdWuHZlnMgqw8_fdW9SzlWpg4YzteHE_JN1uTScvyHOHKemRnfZLslcuDsgj22Xy1wF5PHXvz1-R32AVVO00QpeGdqev9Aa5OdtNQ_FsltaYsDGkSGq9GNIafMKQqkVBV1gmAgCV5mgva1o1tOpb6bZ4wx8Q2q63ifEouf1UV7YRrbL3uFpuWpCic1X9VNgCkzp61-Y1uTj5Nj-e-K5Hg5_zKGn9rOSF0FEh0pIFWhijeKKLWLCY55lBMFmGCiCk4ipkKox0EJsQDATiyFQbAEdvyGCxXJTvCBWlKFismAIMGxcagFuec8NEYniWx4nySNypReaOwBz7aNSyy1S7lk6bErUpMWOPBR4Z9WIry-DxkEDS6Vx25angUCXsMQ8JpncJlo1zC40MZcNkIP8yXY-IXvKW9f_LoIe3zLJ_RuSWQzZJj3zp7FSC68D3QaDZ5QZmk0YRdkfF8ek910A0L5BwKPLIW2vjuwGQ-z-M4vf_P_nP5MlkPj2X56ezsw_kKfzCbEb8RzJo15vyEwC-Vh-6P_QfXutVDA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+of+diabetes+mellitus+with+liver%2C+colon%2C+lung%2C+and+prostate+cancer+is+independent+of+hypertension%2C+hyperlipidemia%2C+and+gout+in+Taiwanese+patients&rft.jtitle=Metabolism%2C+clinical+and+experimental&rft.au=Lee%2C+Mei-Yueh&rft.au=Lin%2C+Kun-Der&rft.au=Hsiao%2C+Pi-Jung&rft.au=Shin%2C+Shyi-Jang&rft.date=2012-02-01&rft.issn=0026-0495&rft.volume=61&rft.issue=2+p.242-249&rft.spage=242&rft.epage=249&rft_id=info:doi/10.1016%2Fj.metabol.2011.06.020&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00260495%2FS0026049511X00136%2Fcov150h.gif